| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |